z-logo
Premium
4‐Aminoquinoline‐Triazine‐Based Hybrids with Improved In Vitro Antimalarial Activity Against CQ ‐Sensitive and CQ ‐Resistant Strains of P lasmodium falciparum
Author(s) -
Manohar Sunny,
Khan Shabana I.,
Rawat Diwan S.
Publication year - 2013
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12108
Subject(s) - chloroquine , plasmodium falciparum , in vitro , moiety , chemistry , potency , triazine , clone (java method) , pharmacology , stereochemistry , biochemistry , biology , malaria , dna , immunology , organic chemistry
A systematic chemical modification in the triazine moiety covalently attached via suitable linkers to 4‐amino‐7‐chloroquinolines yielded a series of new 7‐chloro‐4‐aminoquinoline‐triazine hybrids exhibiting high in vitro activity against W 2 (chloroquine‐resistant) and D 6 (chloroquine‐sensitive) strains of P lasmodium falciparum without any toxicity against mammalian cell lines ( V ero, LLC ‐ PK 11, H ep G 2). Many of the compounds ( 6, 8, 10, 11, 13, 14, 16, 27, 29 and 33 ) showed excellent potency against chloroquine sensitive and resistant strains. In particular, compounds 6, 8 , 14 , 16 and 29 were found to be significantly more active than chloroquine against the chloroquine‐resistant strains ( W 2 clone) of P . falciparum .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom